Our pioneering LiDia-SEQ™ DNA sequencing system will host a range of tests that will provide vital, actionable information to clinicians at the point-of-need, helping save patients’ lives.
Easy to operate by non-specialist users
Results in 3-4 hours at the point-of-need
Highly sensitive and specific
LiDia-SEQ™ combines powerful analytical capability and accurate results with speed and simplicity of use
Diagnostic tests are in development for multiple healthcare applications where rapid point-of-need diagnostics are of critical need:
Bloodstream infection (BSI) pathogen identification
Viral and pandemic
Liquid biopsy for diagnostics and monitoring
OUR LEADING PROGRAM
DNAe’s initial focus is on developing infectious disease diagnostics, where speed and DNA sequence information can make the difference between life and death. This includes a range of tests, starting with a groundbreaking test for bloodstream infections (BSI) and antimicrobial resistance (AMR), which uses whole blood specimens to detect and identify infections that lead to sepsis.
The diagnostic will rapidly identify what infection a patient has, as well as any associated antimicrobial resistance. This will provide clinicians with actionable information to help select the appropriate antibiotics to treat the disease.
For Research Use Only. Not for use in diagnostic procedures. For illustrative purposes only.
Three simple steps
Add 10ml blood Vacutainer™
Results viewed after
3-4 hours on a
Insert the cartridge
DNAe Group Holdings Ltd
Ugli Campus Block C
56 Wood Lane
DNA Electronics, Inc.
1891 Rutherford Road
Carlsbad, CA 92008
+1 (760) 444-9410
KEEP IN TOUCH